Home › Kanser sa Prostate › Hawaii
Pag-aaral pangklinika para sa Kanser sa Prostate sa Hawaii
6 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Hawaii.
Mga Lungsod sa Hawaii
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente Moanalua Medical Center, Honolulu
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Tripler Army Medical Center, Honolulu
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06632977Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Kaiser Permanente Moanalua Medical Center, Honolulu
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06931340Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- at 8 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 23, 2026 · NCT05946213Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Honolulu
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 15, 2026 · NCT07711002Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- at 14 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.